Effect of thyroid nodule size on cytology reliability and incidence of malignancy: A large cohort of 1205 patients from a single center - 01/04/23
, Murat Calapkulu a, Hayri Bostan a, Davut Sakiz a, Sema Hepsen a, Muhammed Kizilgul a, Ilknur Ozturk Unsal a, Ozgur Ozcelik a, Emre Arslan a, Bekir Ucan a, Cem Azili b, Mustafa Ozbek a, Erman Cakal a
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Objective |
There is controversy about whether the rates of malignancy and of false-negative malignancy are greater in large nodules. The aim of this study was to determine the reliability of cytology in ≥4cm nodules and to compare malignancy rates between ≥4cm and<4cm nodules.
Methods |
The study included 1205 patients who underwent biopsy and subsequent thyroidectomy with the diagnosis of nodular thyroid disease between 2014 and 2019. The patients were separated into two groups, ≥4cm and<4cm, according to the size of the index nodule on ultrasonography.
Results |
Two hundred and eleven index nodules (17.5%) were ≥4cm. Malignancy rate on definitive pathology was 51% in<4cm nodules and 30% in ≥4cm nodules. Malignancy risk was significantly lower in ≥4cm nodules than <4cm nodules (P<0.001). When<1cm nodules were excluded and 1–4cm and ≥4cm nodules were compared, malignancy risk was also significantly lower in ≥4cm nodules (P=0.001). On definitive pathology, there were 45 false-negative results among cytologically benign nodules. There was no difference in false-negative cytology rate between<4cm and ≥4cm nodules (P=0.209).
Conclusion |
The present study found no decrease in the reliability of cytology in ≥4cm nodules, and there may not be a linear relationship between nodule size and malignancy risk. Therefore, in asymptomatic cytologically benign ≥4cm nodules, surgery may not be recommended based on nodule size alone.
Le texte complet de cet article est disponible en PDF.Keywords : Thyroid nodules, Cytology, Nodule size, Thyroid cancer
Plan
Vol 84 - N° 2
P. 238-241 - avril 2023 Retour au numéro
Article précédent
- The Rapid Responses to Steroid Hormones meetings: An important event for steroid science
- Yves Jacquot, Patricia de Cremoux, Brian J. Harvey, Martin Wehling
- Modified dynamic risk stratification system further predicts individual outcome in patients with intermediate-risk papillary thyroid cancer
- Diana Isabel Cuéllar, Amelia De los Reyes, Augusto Llamas-Olier
Bienvenue sur EM-consulte, la référence des professionnels de santé.